STAT+: Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
STAT
APRIL 12, 2024
Often, these treatments — which target small patient populations of 200,000 or less people — carry high price tags, which the pharmaceutical industry argues simply reflects large investments for testing and development. Continue to STAT+ to read the full story…
Let's personalize your content